Details for New Drug Application (NDA): 021437
✉ Email this page to a colleague
The generic ingredient in INSPRA is eplerenone. There are five drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the eplerenone profile page.
Summary for 021437
Tradename: | INSPRA |
Applicant: | Upjohn |
Ingredient: | eplerenone |
Patents: | 0 |
Pharmacology for NDA: 021437
Mechanism of Action | Aldosterone Antagonists |
Suppliers and Packaging for NDA: 021437
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
INSPRA | eplerenone | TABLET;ORAL | 021437 | NDA | Pfizer Laboratories Div Pfizer Inc | 0025-1710 | 0025-1710-01 | 30 TABLET, FILM COATED in 1 BOTTLE (0025-1710-01) |
INSPRA | eplerenone | TABLET;ORAL | 021437 | NDA | Pfizer Laboratories Div Pfizer Inc | 0025-1720 | 0025-1720-03 | 30 TABLET, FILM COATED in 1 BOTTLE (0025-1720-03) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | Sep 27, 2002 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
Approval Date: | Sep 27, 2002 | TE: | AB | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
Approval Date: | Sep 27, 2002 | TE: | RLD: | No |
Expired US Patents for NDA 021437
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Upjohn | INSPRA | eplerenone | TABLET;ORAL | 021437-002 | Sep 27, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | INSPRA | eplerenone | TABLET;ORAL | 021437-002 | Sep 27, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | INSPRA | eplerenone | TABLET;ORAL | 021437-002 | Sep 27, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | INSPRA | eplerenone | TABLET;ORAL | 021437-001 | Sep 27, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | INSPRA | eplerenone | TABLET;ORAL | 021437-003 | Sep 27, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | INSPRA | eplerenone | TABLET;ORAL | 021437-003 | Sep 27, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | INSPRA | eplerenone | TABLET;ORAL | 021437-001 | Sep 27, 2002 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription